MMP9 as marker of endometrial cancer

Eva Colas; Jaume Reventos; Elena Martinez Garcia; Bruno Domon; Antoine Lesur

MMP9 as marker of endometrial cancer

Eva Colas (Inventor), Jaume Reventos (Inventor), Elena Martinez Garcia (Inventor), Bruno Domon (Inventor), Antoine Lesur (Inventor)

Research output: Patent

Abstract

The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.

Original language	English
IPC	WO 2017/190896
Publication status	Published - 9 Nov 2017

Cite this

@misc{4d183b0bc8bc41a6a07ee677fc0db5dc,

title = "MMP9 as marker of endometrial cancer",

abstract = "The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.",

author = "Eva Colas and Jaume Reventos and {Martinez Garcia}, Elena and Bruno Domon and Antoine Lesur",

year = "2017",

month = nov,

day = "9",

language = "English",

type = "Patent",

note = "WO 2017/190896",

}

TY - PAT

T1 - MMP9 as marker of endometrial cancer

AU - Colas, Eva

AU - Reventos, Jaume

AU - Martinez Garcia, Elena

AU - Domon, Bruno

AU - Lesur, Antoine

PY - 2017/11/9

Y1 - 2017/11/9

N2 - The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.

AB - The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.

M3 - Patent

ER -

MMP9 as marker of endometrial cancer

Abstract

Fingerprint

Cite this